iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced results from two large real-world ...
American Association of Individual Investors6d
Which Is a Better Investment, Globus Medical, Inc. or iRhythm Technologies, Inc. Stock?
Learn more about whether Globus Medical, Inc. or iRhythm Technologies, Inc. is a better investment based on AAII's A+ ...
AI Predicts Sudden Cardiac Arrest Days Before It Strikes
AI can now predict deadly heart arrhythmias up to two weeks in advance, potentially transforming cardiac care. Artificial ...
Artificial intelligence can aid in the prevention of sudden cardiac death
Many cases of sudden cardiac death could be avoided thanks to artificial intelligence. As part of a new study published in ...
Seeking Alpha6d
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc (IRTC). (NASDAQ:IRTC) today announced results from two large real-world retrospective analyses presented at the American ...
Mena FN6d
Irhythm Unveils New Real-World Data At ACC.25 Demonstrating The Benefits Of Zio® Long-Term Continuous Monitoring For Arrhythmia Detection
(MENAFN- GlobeNewsWire - Nasdaq) Two large studies of over one million patients reveal that short-term Holter-duration monitoring frequently misses actionable arrhythmias and that patient-reported ...
Taiwan News6d
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
Two large studies of over one million patients reveal that short-term Holter-duration monitoring frequently misses actionable arrhythmias and that patient-reported symptoms are an unreliable predictor ...
MedPage Today on MSN5d
Runners' Cardiac Toll Down; IABP Flop in Cardiogenic Shock; Progress on Oral PCSK9i
The full results of the phase III REVERSE-IT trial continue to show that ticagrelor (Brilinta)-reversing therapy bentracimab ...
American Association of Individual Investors13d
Which Is a Better Investment, iRhythm Technologies, Inc. or PROCEPT BioRobotics Corporation Stock?
Learn more about whether iRhythm Technologies, Inc. or PROCEPT BioRobotics Corporation is a better investment based on AAII's ...
New AI ECG Analysis Detects Signs Of Deadly Arrhythmia Before It Strikes With 70% Accuracy
In a new study, researchers have developed an AI-powered neural network capable of identifying patients at risk of life-threatening arrhythmias. By analyzing over 240,000 electrocardiograms, the ...